Promising antibody combo offers hope for children with stubborn neuroblastoma
Disease control
Recruiting now
This study tests a drug called naxitamab, given with GM-CSF, in children and adults with high-risk neuroblastoma that hasn't fully responded to standard treatments. The goal is to see if this combination can shrink or eliminate tumors in the bone or bone marrow. Participants rece…
Phase: PHASE2 • Sponsor: Y-mAbs Therapeutics • Aim: Disease control
Last updated May 03, 2026 21:14 UTC